1. Home
  2. JELD vs RAPP Comparison

JELD vs RAPP Comparison

Compare JELD & RAPP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • JELD
  • RAPP
  • Stock Information
  • Founded
  • JELD 1960
  • RAPP 2022
  • Country
  • JELD United States
  • RAPP United States
  • Employees
  • JELD N/A
  • RAPP N/A
  • Industry
  • JELD Forest Products
  • RAPP
  • Sector
  • JELD Basic Materials
  • RAPP
  • Exchange
  • JELD Nasdaq
  • RAPP Nasdaq
  • Market Cap
  • JELD 540.5M
  • RAPP 463.8M
  • IPO Year
  • JELD 2017
  • RAPP 2024
  • Fundamental
  • Price
  • JELD $5.16
  • RAPP $10.15
  • Analyst Decision
  • JELD Hold
  • RAPP Strong Buy
  • Analyst Count
  • JELD 8
  • RAPP 5
  • Target Price
  • JELD $8.94
  • RAPP $35.00
  • AVG Volume (30 Days)
  • JELD 1.6M
  • RAPP 259.2K
  • Earning Date
  • JELD 05-05-2025
  • RAPP 05-10-2025
  • Dividend Yield
  • JELD N/A
  • RAPP N/A
  • EPS Growth
  • JELD N/A
  • RAPP N/A
  • EPS
  • JELD N/A
  • RAPP N/A
  • Revenue
  • JELD $3,775,592,000.00
  • RAPP N/A
  • Revenue This Year
  • JELD N/A
  • RAPP N/A
  • Revenue Next Year
  • JELD $4.05
  • RAPP N/A
  • P/E Ratio
  • JELD N/A
  • RAPP N/A
  • Revenue Growth
  • JELD N/A
  • RAPP N/A
  • 52 Week Low
  • JELD $4.91
  • RAPP $6.43
  • 52 Week High
  • JELD $21.75
  • RAPP $29.74
  • Technical
  • Relative Strength Index (RSI)
  • JELD 35.83
  • RAPP N/A
  • Support Level
  • JELD $5.01
  • RAPP N/A
  • Resistance Level
  • JELD $5.37
  • RAPP N/A
  • Average True Range (ATR)
  • JELD 0.39
  • RAPP 0.00
  • MACD
  • JELD -0.02
  • RAPP 0.00
  • Stochastic Oscillator
  • JELD 19.14
  • RAPP 0.00

About JELD JELD-WEN Holding Inc.

JELD-WEN Holding Inc is engaged in door and window manufacturing. The company designs, produces, and distributes interior and exterior building products, offering a selection of doors, windows, walls, and related products. The products are used in the new construction of residential single and multi-family homes and non-residential buildings. The firm's operating segments are North America, Europe, and Australasia. It generates a majority of its revenue from North America.

About RAPP Rapport Therapeutics Inc. Common Stock

Rapport Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovery and development of transformational small-molecule medicines for patients suffering from central nervous system disorders. Its foundational science has elucidated the complexities of neuronal receptor biology and enables the company to map and target certain neuronal receptor complexes. Neuronal receptors are complex assemblies of proteins, comprising receptor principal subunits and their receptor-associated proteins (RAPs), the latter of which play crucial roles in regulating receptor expression and function.

Share on Social Networks: